美国食品和药物管理局关于Mavacamten的不良事件报告系统 (FAERS) 的现实世界药监测研究
Zeynep Yukselen1, Arvind Kumar Venkataramana Raju1, Pramukh Arun Kumar1
1Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA, USA.
概括
这项研究分析了对心脏肌酸酶抑制剂马瓦卡门的现实数据,以确定药物不良反应. 结果证实了已知的副作用,如降低射出分数,并揭示了潜在的新信号.
科学领域:
- 药物监督 药物监督 药物监督
- 心脏病学 心脏病学
- 药品安全 药品安全
背景情况:
- 马瓦卡门是一种FDA批准的心脏肌肉酶抑制剂,用于症状阻塞性多变性心肌病 (HCM).
- 现实世界的安全数据对于理解与药物相关的不良事件至关重要.
- 这项研究侧重于在FDA不良事件报告系统 (FAERS) 中报告的与mavacamten相关的不良药反应 (ADR).
研究的目的:
- 在现实环境中评估与vavacamten相关的副作用.
- 通过不成比例性分析识别潜在的安全信号.
- 将现实世界的发现与现有的临床试验数据进行比较.
主要方法:
- 使用了FAERS数据库,分析了4,500,131份报告.
- 使用了四种信号检测算法:ROR,PRR,BCNN和PGBS.
- 确定了26个与mavacamten相关的副作用的显著不成比例的首选术语 (PT).
主要成果:
- 在2022年1月至2023年9月期间,确定了1004个与mavacamten相关的不良反应.
- 统计学意义上的心脏ADR包括排气率 (EF) 降低,心力衰竭和心房动.
- 像ROR和PRR这样的特定指标量化了这些ADR的不成比例.
结论:
- 现实世界的发现与临床试验中mavacamten的安全数据一致.
- 已确认的ADR包括减少喷射分数,心房动,呼吸障碍和昏迷.
- 确定了潜在的新型ADR信号:尿路感染,痛风和外周胀.
更多相关视频
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
9.8K
08:33Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
1.1K
相关概念视频
01:19Pharmacovigilance
797
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
797
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
01:20Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K